Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study

Am J Hematol. 2024 Mar;99(3):477-479. doi: 10.1002/ajh.27179. Epub 2023 Dec 15.

Authors

Rajshekhar Chakraborty¹, Divaya Bhutani¹, Markus Mapara¹, Ran Reshef¹, Mathew S Maurer¹, Jai Radhakrishnan¹, Suzanne Lentzsch¹

Affiliation

¹ Columbia University Irving Medical Center, New York, New York, USA.

PMID: 38100285
DOI: 10.1002/ajh.27179

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Humans
Immunoglobulin Light-chain Amyloidosis* / drug therapy
Retrospective Studies
Treatment Outcome

Substances

daratumumab
Antibodies, Monoclonal